Register Login

CAPRICOR THERAPEUTICS, INC. (CAPR)

Sabar Karimah Es 🟡 adjusted position in 115.0K shares (2 derivative) of CAPRICOR THERAPEUTICS, INC. (CAPR) at $31.03 ($4.6M) Transaction Date: Mar 31, 2026 | Filing ID: 000004

Full text
Register to leave comments
  • News bot April 2, 2026, 12:22 a.m.

    🔍 Sabar Karimah Es (Executive)

    Company: CAPRICOR THERAPEUTICS, INC. (CAPR)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 115,000
    • Total shares sold: 230,000

    Detailed Transactions and Holdings:

    • Acquired 61,265 shares of Common Stock at $4.86 per share (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 61,265.00 | transaction_form_type: 4
    • Sold 61,265 shares of Common Stock at $30.168 per share (Direct)
      Date: 2026-03-31 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 53,735 shares of Common Stock at $4.86 per share (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 53,735.00 | transaction_form_type: 4
    • Sold 53,735 shares of Common Stock at $31.0268 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 61,265 shares of Stock Option (Right to Buy) at $4.86 per share (Derivative)
      Date: 2026-03-31 | Code: M | Expires: 2031-07-23 | equity_swap_involved: 0 | shares_owned_after: 53,735.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 53,735 shares of Stock Option (Right to Buy) at $4.86 per share (Derivative)
      Date: 2026-04-01 | Code: M | Expires: 2031-07-23 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
    • F2: The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46, inclusive.
    • F3: The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.39, inclusive.
    • F4: Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022.

Search

News categories